The NIH is funding a new study at Weill Cornell that aims to identify the regulatory roles of gene variants involved in Type ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

New research uncovers how cancer-induced nerve injury drives resistance to anti-PD-1 therapy, revealing potential strategies to enhance treatment efficacy.

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

Previous research has shown the recombinant zoster vaccine is more effective than its live-attenuated predecessor, but new ...

In the new study, researchers used the SEER-Medicare-linked database to examine treatment patterns and survival outcomes for ...

Ocaliva, approved for primary biliary cholangitis, faced FDA warnings and restrictions after postmarket data showed higher ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Jennifer Walsh of George Washington University’s School of Nursing warned that limiting COVID-19 vaccine approvals to older ...

Two separate analyses in Health Affairs find the One Big Beautiful Bill creates a loophole that exempts or delays orphan ...

Use of transparent PBMs has surged as employer reliance on the Big Three declines, highlighting shifting strategies to ...

Illuminate Rx is the country’s first pharmacist-designed pharmacy benefits optimizer (PBO), offering transparent, clinically ...